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Abstract
Background: Although, Dan-Lou prescription (DLP) is used for antagonizing check discomfort and heartache, the
pharmacological mechanism has not been clearly illustrated. Our present study aimed to design inflammatory models
induced by LPS in vivo and in vitro to investigate the anti-inflammation of DLP ethanol extract (EEDL) and the potential
mechanisms.
Methods: EEDL was prepared and then analyzed by high performance liquid chromatography (HPLC). Further, the
anti-inflammatory effects of EEDL in vivo was evaluated by measuring inflammation-associated factors includingcytokines,
chemokines and acute phase proteins in lipopolysaccharide (LPS)-induced mice serum and liver. The anti-inflammatory
mechanism exploration of EEDL was performed in LPS-stimulated RAW 264.7 cells. Different effects of EEDL on nitric
oxide (NO) and prostaglandin (PG)E2 secretion were investigated by Griess reagent method and enzyme-linked
immunosorbent assay (ELISA) respectively. Then the mRNA and protein expression of inducible NO synthase (iNOS)
and cyclooxygenase (COX)-2 were measured by real-time reverse-transcription polymerase chain reaction (RT-PCR),
ELISA and Western blot. Other chemokines and acute phase proteins were determined by proteome profile array.
Finally, the ELISA based transcription factor assay was applied to measure the DNA-binding activity of nuclear
transcription factor (NF)-κB p65.
Results: Eight compounds from EEDL have been identified as gallic acid, salvianic acid, puerarin, daidzin, paeoniflorin,
salvianolic acid B, cryptotanshinone, and tanshinone IIA, with amounts of 0.26, 9.84, 10.41, 2.55, 9.44, 3.82, 0.24 and
0.3 mg/kg, respectively. In vivo, EEDL administration antagonized the up-regulation of more than 17 kinds of cytokines,
chemokines and acute phase proteins in LPS-treated mice serum, and inhibited LPS-induced IL-6 mRNA and protein
expression in mice liver tissue. In vitro, LPS-induced NO and PGE2 over-productions were decreased by EEDL treatment.
The mRNA and protein expression of iNOS, COX-2 and IL-6 were similarly inhibited by EEDL treatment, which might be
attributed to decrease the DNA-binding activity of NF-κB p65.
Conclusion: EEDL was valid for anti-inflammation and the potential molecular mechanisms might be due to the
inhibition of of LPS-induced iNOS/NO, COX-2/PGE2 and cytokines expression by antagonizing the activation of NF-κB p65.
Background
Coronary heart disease (CHD) is a common and
frequently-occurring disease [1]. There are more than
3.8 million men and 3.4 million women die of the CHD
each year and have a tendency to increase in recent years
globally [2]. In clinical, Dan-Lou prescription (DLP) is given
to patients with angina pectoris, and has advantages in the
improvement of sputum, the lip empurples, etc. [3–5].
Researchers indicate that the pharmacological effects are
attributed to increasing coronary flow [6], antagonizing
platelet aggregation [7], thrombosis formation [8], hyper-
tention [9], hyperglycemia and hyperlipidemia [10].
DLP is derived from the traditional Chinese medicine for-
mula Gualou Xiebai Banxia Tang which is recorded in the
Synopsis of Prescriptions of the Golden Chamber (Jin-Gui-
Yao-Lue) and has been used for about 2000 years in China.
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DLP is consisted of 10 herbs, including Trichosanthes
kirilowii Maxim. (Cucurbitaceae), Allium macrostemon
Bunge. (Liliaceae), Pueraria lobata (Willd.) Ohwi (Legumi-
nosae), Ligusticum chuanxiong Hort. (Umbelliferae), Salvia
miltiorrhiza Bunge. (Labiatae), Paeonia lactiflora Pall.
(Ranunculaceae), Alisma plantago-aquatica Linn. (Alisma-
taceae), Astragalus membranaceus (Fisch.) Bunge. (Legumi-
nosae), Davallia mariesii Moore ex Bak. (Davalliaceae), and
Curcuma aromatica Salisb. (Zingiberaceae). To further
investigate the chemical composition and pharmacological
mechanism, numerous detection methods have been
established such as liquid chromatography-mass spectrom-
etry (LC-MS), gas chromatography–mass spectrometry
(GC-MS), high performance liquid chromatography-
chemiluminescence detection (HPLC-CL), high perform-
ance liquid chromatography-diode-array detector (HPLC-
DAD) and ultra high performance liquid chromatography/
diode-array detector/quadrupole time-of flight tandem
mass spectrometry (UPLC-DAD-QTOF) [7, 11–14]. In this
study, eight highest level ingredients of DLP ethanol extract
(EEDL), gallic acid, salvianic acid, puerarin, daidzin,
paeoniflorin, salvianolic acid B, cryptotanshinone and
tanshinone IIA, were chosen as marker substances to
investigate pharmacological mechanism.
More and more studies show that inflammation plays
a vital role in CHD [15]. Atherosclerosis acts as the main
cause of CHD and is formerly considered as a bland
lipid storage disease. However, atherosclerosis is actually
a process of inflammation invasion. In the pathological
processes of atherosclerosis, all stages such as initiation,
growth and complication of atherosclerotic plaque involve
an inflammatory response [16]. The circulating inflamma-
tory markers such as C-reactive protein (CRP), serum
amyloid A (SAA), interleukin (IL)-6 and IL-1 receptor
commonly accompany with acute coronary syndromes
[17]. Pharmacological studies demonstrate that many
active components of DLP such as gallic acid [18], puer-
arin [19], paeoniflorin [20], cryptotanshinone [21] and
tanshinone IIA [22] have anti-inflammatory effects by
antagonizing over-expression cyclooxygenase (COX)-2,
inducible nitric oxide synthase (iNOS), IL-6, etc. In
detail, gallic acid inhibits lipopolysaccharide (LPS)-in-
duced inflammation in nuclear transcription factor
(NF)-κB transgenic mice [18], cryptotanshinone sup-
presses LPS-induced mice cytokines secretion via inhib-
ition of NF-κB [21], tanshinone IIA reduces LPS-induced
mice acute lung injury via NF-κB inhibition [22]. For these
facts, propose new strategies from anti-inflammation may
be a new viewpoint for the prediction, prevention, and
treatment of DLP on CHD.
The exploration of EEDL on inflammatory response is
the most fundamental research to illustrate the pharmaco-
logical mechanisms. LPS-induced inflammatory models in
mice and macrophages are widely used to preliminarily
screen anti-inflammatory drugs [23]. In the present study,
we designed inflammatory models induced by LPS in vivo
and in vitro to investigate the anti-inflammation of EEDL
and the potential mechanisms.
Methods
Reagents
The drug powder of DLP was provided by Jilin Connell
Medicine Co., Ltd (Jilin, China). Dulbecco’s modified
Eagle’s medium-high glucose (DMEM), 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT), aspirin and LPS from Escherichia coli 0111:B4
were obtained from Sigma-Aldrich Co. (St. Louis, USA).
IL-6 Mouse ELISA Kit was obtained from eBioscience
(San Diedo, USA). Mammalian Cell Lysis Kit and UNIQ-
10 column Trizol total RNA extraction kit were obtained
from Sangon Biological Engineering Technology & Ser-
vices Co., Ltd (Shanghai, China). Improm-II Reverse Tran-
scription System was purchased from Promega
Corporation (Madison, USA). FastStart Universal SYBR
Green Master (ROX) kit was purchased from Roche
(Mannheim, Germany). BCA Protein Assay Kit was pur-
chased from Thermo Fisher (Rochford, USA). Dexametha-
sone injection was obtained from Shanghai General
Pharmaceutical Co., Ltd. (Shanghai, China). 4-amino-5-
methylamino-2′, 7′-difluorofluorescein diacetate (DAF-
FM-DA) was obtained from Invitrogen (Carlsbad, USA).
Prostaglandin (PG)E2 EIA monoclonal kit and Mouse
Cytokine Array Panel A Array kit were obtained from
R&D Systems, Inc. (Minneapoils, USA). Mouse anti-
cyclooxygenase (COX)-2 monoclonal antibody was from
BD PharMingen (San Diego, USA) and goat anti-Mouse
IgG peroxidase conjugate was from Merck (Darmstadt,
Germany). BAY 11–7082 and Nuclear and Cytoplasmic
Protein Extraction Kit were purchased from Beyotime
Institute of Biotechnology (Haimen, China). Antibody for
iNOS was purchased from Cell Signaling Technology
(Beverly, USA). Goat anti-rabbit IgG peroxidase conjugate
was bought from Merck (Darmstadt, Germany). Tran-
scription Factor Assay Kit for nuclear transcription
factor (NF)-κB p65 was purchased from Thermo Fisher
(Rochford, USA).
Extract preparation
The DLP drug powder (50 g) was extracted with 75 %
ethanol (500 mL) in an ultrasonic bath for 30 min at
room temperature and then filtrated. The extraction
process above mentioned was repeated for three times,
mixed the filtrates and concentrated to 100 mL under
reduced pressure at 60 °C. Finally, the concentrate was ly-
ophilized, sealed and stored lucifugally in 50 mL centrifuge
tube at 4 °C for use. The EEDL was dissolved in DMEM to
obtain the desired concentrations in experiments.
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Quantitative chromatographic analysis
To ensure the consistent results, the constituents of
EEDL were analyzed by HPLC using a Waters 2695 sys-
tem (Waters, New York, USA), which is equipped with a
quaternary pump, an autosampler, an online vacuum
degasser, and an ultraviolet detector. The chromato-
graphic analyses were performed on a Kromasil C18
Column (250 mm × 4.6 mm, 5 μm, Sweden) at 25 °C.
For HPLC analysis, a 5 μL sample was injected into the
column with a constant flow rate of 1.0 mL/min. The
mobile phase consisted of acetonitrile (A) and water
(containing 0.1 % formic acid, v/v, B). The elution was
carried out as follows: 10–11 % A at 0–6 min, 11 %
A at 6–8 min, 11–18 % A at 8–10 min, 18–33 % A
at 10–17 min, 33 % A at 17–20 min, 33–52 % A at
20–21 min, 52–55 % A at 21–25 min, 55–75 % A at
25–26 min, 75–90 % A at 26–35 min, 90 % A at
35–40 min, 90–100 % A at 40–40.1 min. Chromatograms
were monitored at a wavelength of 280 nm [7].
In vivo anti-inflammatory analysis
Animals and acute inflammatory injury
Male ICR mice (18–22 g) were obtained from Beijing
HuaFuKang Bio-technology Co., Ltd. They were group-
housed in cages at constant humidity (55 ± 5 %),
temperature (24 ± 1 °C) and light–dark cycle (on at
7:00 a.m. and off at 7:00 p.m.). All animals were allowed
ad libitum water according to the experimental proto-
cols. Studies were performed in accordance with NIH
Guide for the Care and Use of Laboratory Animals and
protocol was approved by the Ethics Committee of Tianjin
University of Traditional Chinese Medicine (TCM-2009-
037-E12).
Forty-eight mice were randomly divided into 6 groups
(8 mice per group): blank control, LPS (dissolved in ster-
ile pyrogen-free saline solution, 1 mg/kg body weight),
LPS + EEDL (0.25, 1 and 4 g/kg); positive control (LPS +
dexamethasone injection, 10 mg/kg). Mice were firstly
pretreated intraperitoneally (i.p.) with 0.9 % saline, dif-
ferent amount of EEDL and dexamethasone injection,
which were dissolved in 0.9 % saline to make a total
volume of 200 μL. After drug administration for 30 min,
LPS were then i.p. given to mice for 90 min, while blank
control mice received only 0.9 % saline. Subsequently,
mice were anesthetized with ether and blood samples
were collected. Serum was obtained by incubating for
1 h at 37 °C (water bath), and then centrifuged at
3000 rpm for 10 min at 4 °C and stored at −20 °C until
use. Simultaneously, the liver tissues were quickly re-
moved, frozen in liquid nitrogen immediately and stored
at −80 °C until analysis.
Analysis of IL-6 protein and mRNA expression in liver
The IL-6 level in mice liver was detected according to
the manufacturer’s instructions of commercially available
ELISA kits. The protein was quantified by BCA method.
For total RNA extraction, the mice tissues of liver sam-
ples (about 30 mg) were homogenized in 500 μL of Tri-
zol reagent. Real-time RT-PCR was performed according
to a previously described method [23]. The real-time
RT-PCR oligonucleotide primers used for mouse IL-6
and β-actin (internal control) were shown in Table 1.
Cytokine protein array analysis
To screen for different acute phase proteins, cytokines,
and chemokines in mice serum, a protein profile array
kit (Mouse Cytokine Array Panel A) from R&D Systems
(cat.no.ARY006) was performed according to the manu-
facturer’s instructions. Samples of mice serum (150 μL)
were separately run on the array [24–26]. The proteins
were detected including: BLC, C5a, G-CSF, GM-CSF,
I-309, Etoaxin, sICAM-1, IFN-γ, IL-1α, IL-1β, IL-1ra,
IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-10, IL-13, IL-12p70,
IL-16, IL-17, IL-23, IL-27, IP-10, I-TAC, KC, M-CSF, JE,
MCP-5, MIG, MIP-1α, MIP-1β, MIP-2, RANTES, SDF-1,
TARC, TIMP-1, TNF-α and TREM-1. Horseradish perox-
idase chemiluminescent substrate (Millipore Corporation,
USA) was used to detect protein blotting by exposure to
Kodak BioMax Light films. Films were scanned into a
computer and densitometry of the image was performed
using an Image-Pro Plus Software version 6.0 (Media
Cybernetics, Sliver Spring, MD, USA).
Table 1 Real-time RT-PCR oligonucleotide primers
Gene Primer Sequence (5′–3′) PCR product (bp)
β-actin Forward TGTTACCAACTGGGACGACA 165
(NM_007393.3) Reverse GGGGTGTTGAAGGTCTCAAA
iNOS Forward CACCTTGGAGTTCACCCAGT 170
(NM_010927.3) Reverse ACCACTCGTACTTGGGATGC
COX-2 Forward TGAGTACCGCAAACGCTTCTC 151
(NM_011198.3) Reverse TGGACGAGGTTTTTCCACCAG
IL-6 Forward TCCAGTTGCCTTCTTGGGAC 140
(NM_031168.1) Reverse GTGTAATTAAGCCTCCGACTTG
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In vitro anti-inflammatory activities
Cells and cell culture
The murine macrophage cell line RAW 264.7 was ob-
tained from Cell Culture Center of Chinese Academy of
Medical Sciences (Beijing, China). Cells were cultured in
DMEM supplemented with 10 % HI-FBS, 100 U/mL
penicillin and 100 μg/mL streptomycin at 37 °C in a fully
humidified incubator containing 5 % CO2. For all experi-
ments, cells were grown to a confluence of 80–90 %,
and were subjected to no more than seven cell passages.
Drug dilution
EEDL was prepared as above mentioned. Then a series
of concentrations (200, 100, 50 and 25 μg/mL) were
obtained by diluting with DMEM (without phenol red)
which was supplemented with 5 % heat inactivated fetal
bovine serum (HI-FBS) and 0.2 μg/mL LPS.
Analysis of cell viability
RAW 264.7 cells were distributed into 96-well plates
(1.0 × 104 cells per well) for 24 h, and treated with
various concentrations of EEDL (200, 100, 50, and
25 μg/mL), L-NAME (100 μM), and aspirin (100 μM).
In this assay, both L-NAME and aspirin work as positive
control drugs. L-NAME is an inhibitor of NOS, and as-
pirin is a commonly used anti-inflammatory drug which
prevent the transformation of arachidonic acid to both
PGE and thromboxanes by inhibiting COX activity.
After incubated for 20 h, MTT reagent was added to a
final concentration of 0.5 mg/mL and incubated for
an additional 2 h at 37 °C and 5 % CO2. After dis-
carding the medium, the formazan precipitate was
solubilized in 100 μL DMSO, and the absorbance was
recorded at 570 nm using a multifunctional micro-
plate reader (FlexStation 3, Molecular Devices, USA).
Determination of nitrite secretion, intracellular NO
production, iNOS mRNA and protein expression
Nitrite is the stable product from NO and is used as an
indicator of NO secreted into the culture medium.
RAW 264.7 cells, cultured in 96-well plates (5.0 × 104
cells per well) overnight were pretreated with various
concentrations of EEDL (200, 100, 50 and 25 μg/mL),
L-NAME (100 μM) or aspirin (100 μM) containing
0.2 μg/mL LPS. The LPS-treated group and blank
control group was given equal volume of medium
with or without LPS (0.2 μg/mL), respectively. After
24 h, the nitrite concentration accumulated in the culture
supernatants was monitored by Griess reagent system
(Promega, USA). Intracellular NO was detected by using
the NO-sensitive fluorescent dye DAF-FM-DA. In detail,
the RAW 264.7 cells were seeded in 35-mm dishes for
24 h at 37 °C and 5 % CO2, and stimulated with EEDL
(200 μg/mL) and L-NAME (100 μM) in the present of
LPS (0.2 μg/mL) for an additional 24 h. Similarly,
LPS-treated group and blank control group was given equal
volume of medium with or without LPS (0.2 μg/mL), re-
spectively. Subsequently, the culture medium was discarded
and cells were fixed with 4 % paraformaldehyde. Finally,
10 μM DAF-FM-DA was incubated for 1 h and washed
with PBS (pH 7.4) for three times. Digitized images were
picked with a Zeiss LSM 710 confocal laser scanning
microscope with an excitation wavelength of 495 nm and
an emission wavelength of 515 nm. For the detection of
iNOS mRNA expression, cells were collected from 6-well
plates with or without the stimulation of LPS, and per-
formed as earlier described [23].
Assay for PGE2 production, COX-2 mRNA and protein
expression
RAW 264.7 cells were treated with the indicated con-
centrations of EEDL (200, 100 and 50 μg/mL) containing
0.2 μg/mL LPS for 24 h, in addition to the LPS-treated
group and blank control group which was given equal
volume of medium with or without LPS (0.2 μg/mL),
respectively. The cell supernatants were drawn off for
the detection of PGE2 using the PGE2 EIA monoclonal
kit (Minneapoils, USA), and cells were used to measure
the expression of COX-2 protein with cell-based ELISA
as previously reported [23, 27]. The COX-2 mRNA
expression was conducted similarly as earlier described.
Determination of IL-6 mRNA expression and protein
secretion
To determine the level of IL-6 production in cell super-
natants, cells were plated at 1 × 105 cells per well in
48-well plate and stimulated with various concentrations
of EEDL (200, 100 and 50 μg/mL) in the presence of
0.2 μg/mL LPS for an additional 24 h. Similarly, the
LPS-treated group and blank control group was given
equal volume of medium with or without LPS
(0.2 μg/mL), respectively. For the detection of IL-6
mRNA, cells were cultured in 6-well plate with the
density of 1 × 106 cells per well. After stimulation
with LPS, cells were harvested for real-time RT-PCR
as earlier described [23].
Cytokine protein array analysis and western blot
To screen for different acute phase proteins, cytokines,
and chemokines in RAW 264.7 cell lysate, a total protein
content of 20 μg was run on the array and performed as
earlier described. Cell lysate was prepared with a Nuclear
and Cytoplasmic Protein Extraction Kit (Beyotime Institute
of Biotechnology, China) according to the manufacturer’s
protocol. For the protein analysis of iNOS, cells were
seeded in the 6-well plates at a density of 1 × 106 cells per
well. After stimulation with LPS for 24 h, cell lysate was
prepared as above mentioned. Subsequently, BCA method
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was employed to determine the protein concentration, and
equal amounts (40 μg) of protein were subjected to
SDS-PAGE and boiled for 5 min. following transferring
samples onto polyvinylidene fluoride (PVDF) membrane,
TTBS (0.5 % Tween 20, 10 mM Tris–HCl, pH 7.5,
150 mM NaCl) containing 5 % nonfat milk was used for
blocking at room temperature for 1 h. One hour later,
blots were incubated with antibodies against iNOS
(1:500), or β-actin (1:5000) overnight at 4 °C. After wash-
ing, appropriate secondary antibodies were selected for
incubation at room temperature for another 1 h. Finally,
the redundant secondary antibodies were washed and the
protein bands were detected by a chemiluminescence
detection kit (Millipore, Billerica, MA, USA) and exposure
to Kodak BioMax Light films. After the films were scanned
and saved as tagged image file format (TIFF) image files,
images were quantified using Image-Pro Plus version 6.0
(Media Cybernetics, Sliver Spring, MD, USA).
DNA-binding activity of NF-κB p65
RAW 264.7 cells, cultured in 60-mm dishes with a dens-
ity of 1.5 × 106 cells per well, were pretreated with EEDL
(200, 100 and 50 μg/mL) or BAY 11–7082 for 2 h. BAY
11–7082 is a commonly used inhibitor of NF-κB. Then
LPS (with a final concentration of 0.2 μg/mL) was added
for an additional 30 min. The LPS-treated group and
blank control group was given equal volume of medium
with or without LPS (0.2 μg/mL), respectively. Then the
cell lysate was prepared with a Nuclear and Cytoplasmic
Protein Extraction Kit (Beyotime Institute of Biotech-
nology, China) according to the manufacturer’s proto-
col. For the DNA-binding activity of NF-κB p65, BCA
method was applied for the quantification of protein con-
centration. Finally, 3 μg protein was added as the manu-
facture’s instruction of Transcription Factor Assay Kit
(Thermo Fisher Scientific Inc., USA).
Statistical analysis
The Origin 7.5 software (MicroCal, USA) was applied to
perform statistical analysis. N indicated the number of
animals in each group or the number of wells studied in
each category. In vivo experiments, data were expressed
as means ± SE, and in vitro, means ± SD were calculated.
For statistical comparisons, the results were analyzed
using one-way analysis of variance (ANOVA) and a
P < 0.05 was considered statistically significant.
Results
Primary chemical ingredients analysis of EEDL
Analysis of various chemical compounds in EEDL was
performed by HPLC. The typical chromatogram of EEDL
is shown in Fig. 1 and eight compounds from EEDL have
been identified as gallic acid (1), salvianic acid (2), puer-
arin (3), daidzin (4), paeoniflorin (5), salvianolic acid B (6),
cryptotanshinone (7), and tanshinone IIA (8). According
Fig. 1 HPLC analysis of (a) standard solutions and (b) sample of EEDL. “1” gallic acid; “2” salvianic acid; “3” puerarin; “4” daidzin; “5” paeoniflorin;
“6” salvianolic acid B; “7” cryptotanshinone; and “8” tanshinone IIA
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to the calibration curves, the contents of the eight com-
pounds above mentioned in EEDL were quantified. The
amounts of gallic acid, salvianic acid, puerarin, daidzin,
paeoniflorin, salvianolic acid B, cryptotanshinone, and tan-
shinone IIA were 0.26, 9.84, 10.41, 2.55, 9.44, 3.82, 0.24
and 0.3 mg/kg, respectively.
Anti-inflammation of EEDL in vivo
EEDL attenuates the IL-6 mRNA and protein expression in
liver
As a pro-inflammatory cytokine, IL-6 plays a vital role in
the process of inflammation. When mice were i.p.
injected with LPS (1 mg/kg), the IL-6 mRNA (Fig. 2a)
and protein (Fig. 2b) level in mice liver were significantly
increased up to hundreds folds comparing with the blank
control group (P < 0.01). However, dexamethasone injec-
tion or EEDL (0.25, 1 and 4 mg/kg) treatment down-
regulated the aberrant increase of IL-6 mRNA and protein
expression with varying degrees (P < 0.05 or P < 0.01).
Effects of EEDL on multiple cytokines in serum
Previously, we showed that the inflammation induced by
LPS (1 mg/kg) in mice was an inflammatory network
composed of cytokines, chemokines and so on [23]. To
further investigate the anti-inflammation of EEDL, the
proteome profiler array was employed. It allows a simul-
taneous analysis of 40 proteins in a single experiment.
As shown in Fig. 3, LPS resulted in a burst of 17
inflammation-related proteins, including C5/C5a, G-CSF,
I-309, sICAM-1, IL-1ra, IL-6, IP-10, KC, M-CSF, MCP-1,
MIP-1α, MIP-1β, MIP-2, RANTES, SDF-1, TIMP-1 and
TNF-α. Also, LPS decreased the expression of IL-10, an
anti-inflammatory cytokine. However, EEDL administra-
tion (4 mg/kg) not only notably suppressed the over-
expressions of C5/C5a, G-CSF, I-309, sICAM-1, IL-1ra,
IL-6, IP-10, KC, M-CSF, MCP-1, MIP-1α, MIP-1β, MIP-2,
RANTES, SDF-1, TIMP-1, and TNF-α (P < 0.01), but
increased the IL-10 protein levels (P < 0.01).
Anti-inflammation of EEDL in vitro
Cytotoxicity of EEDL on RAW 264.7 cells
The cytotoxicity of EEDL on RAW 264.7 cells was de-
tected with MTT assay. Comparing with the blank control
group, no significant variation of optical density was ob-
served among each group (Additional file 1). It suggested
that all concentrations of EEDL, L-NAME and aspirin
used were not toxic to RAW 264.7 cells.
Effect of EEDL on NO production, iNOS mRNA and protein
expression
To estimate how EEDL modulated inflammation responses,
we first investigated the effect of EEDL on LPS-induced
nitrite accumulation in LPS-induced RAW 264.7 cells.
Results in Fig. 4a showed the nitrite concentrated in
culture medium was increased 4 times after stimulated
by LPS (P < 0.01), and a dose-dependent antagonism
was observed in EEDL treatment group (P < 0.01).
Moreover, the effectiveness of the highest concentration
was better than aspirin but far less than that of L-NAME.
Similarly, confocal scanning micrographs displayed EEDL
was a potential anti-inflammation agent by reducing the
intracellular NO production stimulated by LPS alone
(Fig. 4c).
For the detections of iNOS mRNA and protein ex-
pression, EEDL concentration-dependently decreased
the abnormal iNOS mRNA (Fig. 4b) and protein (Fig. 4d)
(P < 0.01 or P < 0.05) expression. Especially, administrated
with the high dose of EEDL (200 μg/mL) displayed more
potently anti-inflammatory effect (inhibitory rate was
about 90 %) on reducing the mRNA and protein expres-
sions of iNOS compared with positive control group,
pretreated with aspirin.
Fig. 2 Effects of EEDL on LPS-induced IL-6 mRNA and protein
expressions in mice liver. After mice were i.p. administrated with LPS
(1 mg/kg) for 90 min, mice livers were selected for this assay. The
mRNA and protein expressions of IL-6 (a and b) were measured with
real-time RT-PCR and ELISA, respectively. Values are means ± SE (n = 3
for real-time RT-PCR, n= 6 for ELISA) and significant difference compared
with blank control or LPS treated alone, ##P< 0.01 vs. blank control group,
*P < 0.05, **P < 0.01 vs. LPS-treated group
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Effect of EEDL on PGE2 production, COX-2 mRNA and protein
expression
PGE2 is another important inflammatory mediator. Its
production is regulated by COX-2 which catalyzed the
metabolism of arachidonic acid. The high concentration
of PGE2 increases vascular permeability and evokes the
inflammatory reaction. As shown in Fig. 5a, EEDL at 200
and 100 μg/mL possessed significant inhibitory activities on
LPS-induced PGE2 over-production (P < 0.05 or P < 0.01)
and stronger than that of aspirin. For COX-2 mRNA ex-
pression (Fig. 5c), a dose-dependent inhibition was ob-
served (200 μg/mL, P < 0.01). To evaluate the regulation of
EEDL on COX-2 protein expression, cell-based ELISA
(Fig. 5b) was performed. Results depicted that EEDL mark-
edly reduced the LPS-induced COX-2 protein over-
expression (P < 0.05 or P < 0.01).
Effects of EEDL on IL-6 mRNA expression and protein
secretion
As shown in Fig. 6, the dramatic increase of pro-
inflammatory cytokine IL-6 was generally observed fol-
lowing the stimulation with LPS for 24 h. With the
intervention of EEDL, however, IL-6 mRNA and pro-
tein levels were concentration-dependently decreased
(P < 0.05 or P < 0.01). The inhibitory rate of IL-6 pro-
tein secretion was above 50 %.
Effects of EEDL on multiple cytokines in LPS-induced RAW
264.7 cells
As shown in Fig. 7, LPS resulted in a burst of 15
inflammation-related proteins in cell lysate, including C5/
C5a, G-CSF, IL-1α, IL-1β, IL-1ra, IP-10, KC, MCP-1, MIP-
1α, MIP-1β, MIP-2, RANTES, SDF-1, TIMP-1, and TNF-α.
However, EEDL treatment (200 μg/mL) notably alleviated
the over-expressions of C5/C5a, G-CSF, IL-1α, IL-1β,
IL-1ra, IP-10, KC, MCP-1, MIP-1α, MIP-2, RANTES,
SDF-1, TIMP-1, and TNF-α (P < 0.01 or P < 0.05), but
with no significant influence on MIP-1β (P > 0.05).
Effects of EEDL on the DNA-binding activity of NF-κB p65
The activation of NF-κB signaling pathway has been
known to play a critical role in the inflammation response.
As illustrated in Fig. 8, LPS induced a one-fold increase
on the DNA-binding activity of NF-κB p65. After inter-
vened with EEDL for 30 min, however, the over-binding
was decreased by EEDL in a dose-dependent manner
(P < 0.01 or P < 0.05).
Discussion
Mounting evidence highlights that a systemic inflamma-
tory state contributes to the cardiovascular risk [28].
The circulating inflammation mediators take part in the
mechanisms of vascular insult and atheromatous changes.
As a cardiovascular protective agent, many components of
DLP have been proved to have the capacity of anti-
inflammation such as gallic acid [29], salvianic acid [30],
puerarin [13], daidzin [31], paeoniflorin [32], salvianolic
acid B [33], cryptotanshinone [21], and tanshinone IIA
[34]. Here, we presented results from the investigation on
Fig. 3 Effects of EEDL on LPS-induced multiple cytokines production
in mice serum. After mice were pre-treated with EEDL (4 mg/kg) or
0.9 % saline for 30 min, LPS (1 mg/kg) or 0.9 % saline were injected,
respectively, for an additional 90 min. a Expression of multiple proteins
in the acute inflammation was measured by proteome profile array. (a)
Blank control; (b) mice were administrated (i.p.) with LPS alone; (c) mice
were administrated (i.p.) with LPS + EEDL. Numbers marked on the
membranes are presented as: “1” C5/C5a; “2” G-CSF; “3” I-309; “4”
sICAM-1; “5” IL-1a; “6” IL-6; “7” IL-10; “8” IP-10; “9” KC; “10” M-CSF; “11”
MCP-1; “12” MIP-1α; “13” MIP-1β; “14” MIP-2; “15” RANTES; “16” SDF-1;
“17” TIMP-1; “18” TNF-α. b Analysis of optical density was captured by
the Image-Pro Plus version 6.0. Values are means ± S.D. and significant
difference compared with LPS treated alone, **P < 0.01
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the efficacy of EEDL on inflammation induced by LPS in
vivo and in vitro.
Studies have shown that LPS injection in mice caused
significant inflammatory damage (such as biochemical
and histological damage in lung and liver) [23, 35]. In
the present study, we used the mice model to investigate
anti-inflammation of EEDL. Results showed that EEDL
possessed a strong and wide anti-inflammatory effect.
In detail, EEDL was effective for antagonizing the over-
expression of C5/C5a, G-CSF, I-309, sICAM-1, IL-1ra,
IL-6, IP-10, KC, M-CSF, MCP-1, MIP-1α, MIP-1β,
MIP-2, RANTES, SDF-1, TIMP-1, and TNF-α (P <
0.01), and increasing IL-10 protein level in mice serum
(P < 0.01). The in vivo experiments preliminarily indicated
that EEDL might be an effective anti-inflammatory agent.
According to the animal experiments, we tried to fur-
ther explore the anti-inflammation mechanisms on
RAW 264.7 cells, which depicted that treatment of
RAW 264.7 cells with EEDL could modulate the iNOS/
NO, COX-2/PGE2 and cytokine levels by declining the
DNA-binding activity of NF-κB p65. iNOS is an import-
ant enzyme for mediating inflammatory processes. Gen-
erally, NO is at low concentration under physiological
conditions which acts as a vasodilator by inhibiting the
adhesion of neutrophils to the vascular endothelium
[36]. However, large amounts of NO are produced in the
Fig. 4 Effects of EEDL on NO and iNOS levels in LPS-stimulated RAW 264.7 cells. a Nitrite production secreted in the culture medium was monitored by
the Griess reagent system. Values are means ± SD (n= 6) from three independent experiments and significant difference compared with blank control or
LPS treated alone, ##P< 0.01 vs. blank control group, **P < 0.01 vs. LPS-treated group. b RAW 264.7 cells were pretreated with EEDL (200 μg/mL) and
0.2 μg/mL LPS for 18 h. The mRNA expression of iNOS was detected by real-time RT-PCR. Values are means ± SD (n= 3) and significance compared with
blank control or LPS treated alone, ##P< 0.01 vs. blank control group, *P < 0.05, **P < 0.01 vs. LPS-treated group. c Intracellular NO was detected by confocal
laser scanning microscope: (a) blank control; (b) cells pretreated with LPS; (c) cells pretreated with EEDL in the present of LPS; (d) cells pretreated with
100 μM L-NAME in the present of LPS. d The protein expression of iNOS was measured with Western blot. The optical density was captured by the
Image-Pro Plus version 6.0. Values are means ± SD (n = 3) and significant difference compared with blank control or LPS treated alone, ##P < 0.01 vs.
blank control group, **P < 0.01 vs. LPS-treated group
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inflammatory tissue by the activation of iNOS in both
resident tissue cells and infiltrating leucocytes when
inflammation was triggered [37]. In this study, we
found that the production of NO, intracellular NO, as
well as the mRNA and protein expression of iNOS
were all up-regulated by LPS, whereas they were at-
tenuated by EEDL treatment. These results indicated
that the inhibition of iNOS/NO might be one of the
anti-inflammatory targets of EEDL.
In addition to iNOS, COX-2, which is an inducible and
isoform enzyme in inflammatory cells [38], is another vital
enzyme for mediating inflammatory processes. COX-2 is
activated by physiologic stimuli such as inflammation, and
is involved in the production of PGs that mediate pain
and support the inflammatory process [39]. The PGE2,
produced by the enzymatic oxidation of arachidonic acid,
has been implicated as inflammatory mediators for many
years [40]. Additionally, PGs have wide-ranging effects in
the body [38]. In this work, we found that EEDL could
Fig. 5 Effects of EEDL on levels of PGE2 and COX-2 in LPS-stimulated
RAW 264.7 cells. PGE2 production (a) and COX-2 protein (b) and
mRNA expression (C) were detected by ELISA and real-time RT-PCR.
The protein expression of COX-2 (b) was detected by cell-based ELISA.
Values are means ± SD (n = 6 for ELISA, n = 3 for real-time RT-PCR) and
significant difference compared with blank control or LPS treated
alone, ##P < 0.01 vs. blank control group, *P < 0.05, **P < 0.01 vs.
LPS-treated group
Fig. 6 Effects of EEDL on IL-6 mRNA expression and protein secretion in
LPS-stimulated RAW 264.7 cells. RAW 264.7 cells were treated with the
indicated concentrations of EEDL in the presence of LPS (0.2 μg/mL)
for 24 h. The mRNA expression of IL-6 (a) was determined by
real-time RT-PCR. Values are means ± SD (n = 3) and significant
difference compared with blank control or LPS treated alone, ##P < 0.01
vs. blank control group, *P < 0.05 vs. LPS-treated group. The protein
secretion of IL-6 (b) was measured with ELISA. Values are means ± SD
(n = 6) and significant difference compared with blank control or LPS
treated alone, ##P < 0.01 vs. blank control group, **P < 0.01 vs.
LPS-treated group
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remarkably decrease the burst production of PGE2 based
on the detection of EEDL on LPS-induced inflammation.
Moreover, the cell-based ELISA showed that EEDL
could dose-dependently antagonize the over-expression
of COX-2, which depicted that inhibition of COX-2/
PGE2 might be another anti-inflammatory target.
Numerous pro-inflammatory cytokines are present in
the inflammation process, such as IL-1, TNF, macrophage
inflammatory protein (MIP). Firstly, we found that EEDL
effectively attenuated the over-expression of IL-6 mRNA
and protein induced by LPS in a concentrate-dependent
manner. In addition to the ELISA method, protein profile
array analysis, a high-throughput way to screen the differ-
ent acute phase proteins, cytokines, and chemokines in a
particular inflammatory process, further indicated that
EEDL suppressed LPS-induced inflammation via decreas-
ing multiple pro-inflammatory cytokines such as the com-
mon IL-1β, TNF-α, MIP-2.
Studies have demonstrated that NF-κB is involved in
the regulation of COX-2 and iNOS expression, namely,
blocking the improper NF-κB activation could inhibit
the expression of COX-2 and iNOS [41]. Syntheses of
cytokines, such as IL-1β, TNF-α, IL-6, are also mediated
by NF-κB [42]. Various proteins in NF-κB family play an
important role in the defense of the host against certain
pathogens [42]. For example, studies have shown that
NF-κB p65 plays a role in constitutive IL-6 production
in rheumatoid arthritis synovial fibroblasts. In this study,
we designed experiment to investigate the DNA-binding
activity of NF-κB p65 by transcription factor assay,
which showed that the LPS-stimulated NF-κB activation
was notably inhibited by EEDL, as indicated by a decreased
DNA-binding activity of NF-κB p65.
Conclusions
We have unraveled a novel pharmacological effect
that EEDL effectively suppressed the inflammation
induced by LPS in mice. The anti-inflammation of
EEDL may be one of the mechanisms of cardiovascular
Fig. 7 Effects of EEDL on LPS-induced multiple cytokines production
in RAW 264.7 cells. a Expression of multiple proteins in the acute
inflammation was measured by proteome profile array. (a) Blank
control; (b) RAW 264.7 cells were treated with LPS alone; (c)
RAW 264.7 cells were treated with LPS + EEDL. Numbers marked
on the membranes are presented as: “1” C5/C5a; “2” G-CSF; “3”
IL-1α; “4” IL-1β; “5” IL-1ra; “6” IP-10; “7” KC; “8” MCP-1; “9” MIP-1α;
“10” MIP-1β; “11” MIP-2; “12” RANTES; “13” SDF-1; “14” TIMP-1;
“15” TNF-α. b Analysis of optical density was captured by the
Image-Pro Plus version 6.0. Values are means ± SD and significant
difference compared with LPS treated alone, *P < 0.05, **P < 0.01
Fig. 8 Effects of EEDL on LPS-induced DNA-binding activity of NF-κB
p65 in RAW 264.7 cells. RAW 264.7 cells cultured in 6-well plate were
pre-treated with EEDL (200, 100 and 50 μg/mL) for 2 h, then the LPS
(with a final concentration of 0.2 μg/mL) was added for another 30 min,
then the cell lysates were extracted and quantified. The DNA-binding
activity of NF-κB p65 was measured by transcription factor assay. Values
are means ± SD (n= 6) and significant difference compared with blank
control or LPS treated alone, ##P< 0.01 vs. blank control group, *P < 0.05,
**P < 0.01 vs. LPS-treated group
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and cerebrovascular disease. Meanwhile, we have pre-
liminarily deciphered the potential molecular mechanisms
of EEDL, namely, inhibiting the LPS-induced iNOS/NO,
COX-2/PGE2 and cytokines levels by decreasing the DNA-
binding activity of NF-κB p65. However, we also aware that
further researches are needed to obtain more definitive
evidence for the deeper exploration.
Additional file
Additional file 1: Cytotoxicity of EEDL on RAW 264.7 cells. Cells
cultured in the 96-well plate for 24 h were incubated with L-NAME (100 μM),
aspirin (100 μM) and indicated dilutions of EEDL (200, 100, 50 and 25 μg/mL)
in the presence of LPS (0.2 μg/mL) for 20 h. After MTT reagent was added for
an additional 2 h, the absorbance was recorded at 570 nm. Values are means
± SD (n=6) from three independent experiments and there is no significant
difference compared with LPS treated cells alone. (TIFF 284 kb)
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